GK
Girish Kulkarni
Intas Pharmaceuticals Ltd, Alembic Pharmaceuticals Ltd, Glenmark Pharmaceuticals Ltd
0000-0002-9507-0217
Employment
-
Intas Pharmaceuticals Ltd Associate Vice-President2016 - Present
-
Alembic Pharmaceuticals Ltd DGM2013 - 2016
-
Glenmark Pharmaceuticals Ltd Marketing Manager2005 - 2013
-
Zydus Cadila ABM2004 - 2005
-
Sun Pharmaceutical Industries Ltd ABM2001 - 2004
Education
Education history is unavailable.
Projects & Funding
Projects & funding information is unavailable.
Publications (15)
- GLIMSI: A real-world, multicenter study assessing the effectiveness and safety of Sitagliptin + Glimepiride + Metformin FDC in Indian patients with Type 2 diabetes Save
- Real world observational study investigating clinical effectiveness and safety of lacosamide in epilepsy: ULTIMATE study Save
- Real‐World Efficacy and Safety of Cuticapil Stem Hair Serum as an Add‐On to Minoxidil in Androgenetic Alopecia: A Prospective Observational Study Save
- A multicenter, cross-sectional analysis to assess the safety and usage pattern of brivaracetam in the management of partial-onset seizure with BAEs—BREEZE study: A post-hoc analysis Save
- First clinical post-approval, observational study to assess clinical safety and effectiveness of brivaracetam sustained-release formulation in real-life settings of India: BEAM study Save
- Health tourism in the era of COVID-19: a bibliometric analysis Save
- Cross-Sectional Analyses to Assess the Clinical Safety and Effectiveness of Bisoprolol in Patients With Non-obstructive Coronary Artery Disease Who Underwent Percutaneous Coronary Intervention: A Post-hoc Analysis Save
- P026 A PRESCRIPTION TREND ANALYSIS OF ANTIHYPERTENSIVE PHARMACOTHERAPY ACROSS DIFFERENT SPECIALTIES IN INDIA Save
- A PRESCRIPTION TREND ANALYSIS OF ANTIHYPERTENSIVE PHARMACOTHERAPY ACROSS DIFFERENT SPECIALTIES IN INDIA Save
- Case cohort analysis to assess clinical utilization of vortioxetine in major depressive disorder: VALUE Study Save